Replies to post #216008 on Biotech Values

[Titan V]

SAGE has shown that success in PPD is translatable in MDD. If MRNS provides positive PPD, I think they are going to get acquired to speed up MDD trial. They also presented positive p2 data in CDKL5 (an Orphan indication) in September. Lastly, for what it’s worth, Bain Capital Life Sciences led MRNS’ last offering at $3.75. Transactions are in Bain’s blood. If PPD is positive I think they will push the board to sell the company (15 employees only).